Shree Ram Proteins Ltd. (SRPL) AI Stock Analysis

0 Followers

Shree Ram Proteins Ltd.

(NSE:SRPL)

Select Model

Rating:44Neutral

Price Target:INR 0.33▼(-2.94% Downside)

Action:upgraded

Date:09/24/26

The score is held down primarily by very weak financial performance, including multi-year losses, a collapse in revenue, rising leverage, and eroding equity. Technicals are only mildly supportive with a weak longer-term trend and mixed momentum signals. Valuation is constrained by loss-making results (negative P/E) and no available dividend yield.

Positive Factors

Historical ProfitabilityThe company demonstrated an ability to generate profit in three consecutive years before the recent downturn. This history shows that the operating model has previously supported positive earnings, providing a foundation for recovery if revenue and margins stabilize.

Negative Factors

Severe Earnings DeteriorationThe shift from recurring profits to three consecutive years of large losses indicates a substantial deterioration in the economics of the business. Persistent losses can weaken reinvestment capacity, reduce financial resilience, and make a durable earnings recovery dependent on restoring operations and margins.

Shree Ram Proteins Ltd. (SRPL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 145.66M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.5
Beta (1Y): 0.48
Revenue Growth: ―
EPS Growth: 43.06%
Country: India
Employees: 24
Sector: General
Sector Strength: 55
Industry: Agricultural Farm Products

Shree Ram Proteins Ltd. Business Overview & Revenue Model

Company Description

Shree Ram Proteins Limited, an Indian company, specializes in the processing of cotton seeds. Its product portfolio is extensive, featuring various cotton seed derivatives like linter, meal, hull, and both wash and refined oils. Beyond cotton, the co...

How the Company Makes Money

SRPL generates revenue primarily through the sale of agricultural commodity products and related processed outputs (i.e., revenue recognized when commodities/finished goods are delivered/sold to customers). Key revenue streams typically include (a) t...

Shree Ram Proteins Ltd. Financial Statement Overview

Summary

Income statement weakness dominates: the company shifted from profits in FY2021–FY2023 to large losses in FY2024–FY2026, with revenue volatility and a collapse to zero in FY2025–FY2026. Balance-sheet risk has increased as equity eroded sharply and debt-to-equity rose materially (up to ~2.42 by FY2026). Cash flow is highly inconsistent with limited coverage versus debt outside of FY2022, adding uncertainty around sustainability.

Income Statement

12Very Negative

Balance Sheet

33Negative

Cash Flow

26Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	146.00K	0	0	147.66M	1.63B	2.88B
Gross Profit	-60.85M	-61.39M	-195.24M	-45.57M	145.69M	174.93M
EBITDA	-79.56M	-91.70M	-169.38M	-78.65M	105.07M	136.20M
Net Income	-146.53M	-101.08M	-210.75M	-95.85M	38.45M	61.41M
Balance Sheet
Total Assets	0	694.70M	787.27M	982.56M	1.06B	1.16B
Cash, Cash Equivalents and Short-Term Investments	135.00K	135.00K	136.00K	970.00K	425.00K	313.31M
Total Debt	0	371.45M	381.37M	369.40M	369.48M	425.14M
Total Liabilities	-153.42M	541.28M	532.49M	517.65M	500.07M	638.17M
Stockholders Equity	153.42M	153.42M	254.79M	464.91M	560.73M	522.31M
Cash Flow
Free Cash Flow	0	9.73M	-12.81M	5.83M	-214.48M	360.12M
Operating Cash Flow	0	9.73M	-12.81M	5.86M	-202.00M	362.66M
Investing Cash Flow	0	283.00K	0	9.04M	-12.39M	-2.44M
Financing Cash Flow	0	-10.02M	11.97M	-14.35M	-98.50M	-56.87M

Shree Ram Proteins Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price0.34

Price Trends

50DMA0.34Neutral

100DMA0.34Negative

200DMA0.41Negative

Market Momentum

MACD-0.00Negative

RSI42.95Neutral

STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SRPL, the sentiment is Negative. The current price of 0.34 is above the 20-day moving average (MA) of 0.34, equal to the 50-day MA of 0.34, and below the 200-day MA of 0.41, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SRPL.

Shree Ram Proteins Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:SRPL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:MGEL	77Outperform	INR 5.79B	14.96	―	0.06%	44.23%	8.18%
IN:GODREJAGRO	72Outperform	INR 113.86B	25.25	―	1.88%	11.64%	7.78%
IN:DBOL	69Neutral	INR 9.16B	10.90	―	1.08%	10.24%	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:VENKEYS	53Neutral	INR 22.23B	12.63	―	0.64%	18.28%	202.79%
IN:SRPL	44Neutral	INR 145.66M	-0.50	―	―	―	43.06%
IN:SANWARIA	43Neutral	INR 360.69M	-3.51	―	―	296.49%	19.23%

* General Sector Average

Performance Comparison

IN:SRPL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:SRPL	Shree Ram Proteins Ltd.	0.34	-0.34	-50.00%
IN:DBOL	Dhampur Bio Organics Ltd	138.90	66.51	91.87%
IN:GODREJAGRO	Godrej Agrovet Limited	586.25	12.01	2.09%
IN:MGEL	Mangalam Global Enterprise Ltd.	17.70	3.69	26.33%
IN:SANWARIA	Sanwaria Consumer Ltd	0.49	0.00	0.00%
IN:VENKEYS	Venky's (India) Limited	1557.40	215.91	16.09%

Shree Ram Proteins Ltd. Corporate Events

Shree Ram Proteins Shareholders Approve Related-Party Sale of Undertaking via E-Voting

Aug 18, 2026

Shree Ram Proteins Ltd. conducted an Extraordinary General Meeting (EOGM) on March 5, 2026, via video conferencing, where shareholders participated through remote and live e-voting facilitated by NSDL in compliance with Ministry of Corporate Affairs...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026

Shree Ram Proteins Ltd. AI Stock Analysis